Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.52k | 0.80% |
| 2026-05-28 | Dr. Manuel Hidalgo MedinaIndependent Director | -1,000.00 | 130.06k | 売り | 130.06 | 639.00 | -61.01% |
| 2026-05-27 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -10.00k | 1.25M | 売り | 125.08 - 126.08 | 35.95k | -21.76% |
| 2026-05-22 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -24.41k | 2.09M | Derivative Exercise and Sale | 32.86 - 118.67 | 60.03k | - |
| 2026-05-20 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -20.00k | 2.13M | 売り | 105.34 - 107.23 | 45.95k | -30.33% |
| 2026-05-20 | Dr. AmirAli TalasazCo-CEO & Director | -210.00k | 23.08M | 売り | 100.95 - 112.76 | 1.89M | -10.02% |
| 2026-05-20 | Dr. Manuel Hidalgo MedinaIndependent Director | -250.00 | 26.77k | 売り | 107.07 | 1.64k | -13.23% |
| 2026-05-20 | Dr. Manuel Hidalgo MedinaIndependent Director | -1,000.00 | 74.55k | Derivative Exercise and Sale | 32.55 - 107.10 | 1.64k | - |
| 2026-05-20 | Mr. Ian T. ClarkLead Independent Director | -6.88k | 735.05k | 売り | 106.90 | 2.98k | -69.80% |
| 2026-05-15 | Mr. Musa TariqIndependent Director | -116.00 | 11.13k | Derivative Exercise and Sale | 95.96 | 8.66k | - |
| 2026-05-15 | Mr. Musa TariqIndependent Director | 134.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.66k | 1.57% |
| 2026-05-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.89k | 14.00% |
| 2026-05-15 | Dr. Darya ChudovaCTO | -4.68k | 444.13k | Derivative Exercise and Sale | 94.92 | 83.94k | - |
| 2026-05-15 | Dr. Darya ChudovaCTO | 4.03k | 0.00 | Derivative Exercise and Retained Stock | - | 83.94k | 5.04% |
| 2026-05-12 | Dr. AmirAli TalasazCo-CEO & Director | -50.00k | 5.02M | 売り | 100.32 | 2.10M | -2.33% |
| 2026-04-30 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.36k | 0.80% |
| 2026-04-21 | Mr. Roberto Agostino MignoneIndependent Director | 264.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.75k | 5.88% |
| 2026-04-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.66k | 16.28% |
| 2026-04-15 | Mr. Musa TariqIndependent Director | 134.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.53k | 1.60% |
| 2026-04-15 | Mr. Musa TariqIndependent Director | -116.00 | 9.84k | Derivative Exercise and Sale | 84.83 | 8.53k | - |
| 2026-04-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 3.60k | 0.00 | Derivative Exercise and Retained Stock | - | 65.95k | 5.77% |
| 2026-04-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -3.97k | 336.89k | Derivative Exercise and Sale | 84.86 | 65.95k | - |
| 2026-04-06 | Ms. Terilyn Juarez MonroeCPO | -3.83k | 355.15k | 売り | 92.68 | 20.99k | -15.44% |
| 2026-04-01 | Ms. Terilyn Juarez MonroeCPO | 3.83k | 0.00 | Derivative Exercise and Retained Stock | - | 24.82k | 18.26% |
| 2026-04-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 5.45k | 0.00 | Derivative Exercise and Retained Stock | - | 62.35k | 9.57% |
| 2026-04-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -6.01k | 548.08k | Derivative Exercise and Sale | 91.15 | 62.35k | - |
| 2026-04-01 | Ms. Terilyn Juarez MonroeCPO | -4.19k | 381.65k | Derivative Exercise and Sale | 91.15 | 24.82k | - |
| 2026-04-01 | Mr. Kumud KaliaChief Information Officer | 4.95k | 0.00 | Derivative Exercise and Retained Stock | - | 49.25k | 11.18% |
| 2026-04-01 | Mr. Kumud KaliaChief Information Officer | -5.09k | 464.14k | Derivative Exercise and Sale | 91.15 | 49.25k | - |
| 2026-04-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 6.46k | 0.00 | Derivative Exercise and Retained Stock | - | 60.03k | 12.06% |
| 2026-04-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -4.75k | 432.96k | Derivative Exercise and Sale | 91.15 | 60.03k | - |
| 2026-04-01 | Dr. Craig Eagleインサイダー | 5.62k | 0.00 | Derivative Exercise and Retained Stock | - | 72.00k | 8.47% |
| 2026-04-01 | Dr. Craig Eagleインサイダー | -5.78k | 526.76k | Derivative Exercise and Sale | 91.15 | 72.00k | - |
| 2026-04-01 | Mr. Michael BellCFO | 5.91k | 0.00 | Derivative Exercise and Retained Stock | - | 49.51k | 13.55% |
| 2026-04-01 | Mr. Michael BellCFO | -6.87k | 626.11k | Derivative Exercise and Sale | 91.15 | 49.51k | - |
| 2026-04-01 | Dr. Darya ChudovaCTO | 6.02k | 0.00 | Derivative Exercise and Retained Stock | - | 79.91k | 8.15% |
| 2026-04-01 | Dr. Darya ChudovaCTO | -7.01k | 638.51k | Derivative Exercise and Sale | 91.15 | 79.91k | - |
| 2026-03-31 | Dr. AmirAli TalasazCo-CEO & Director | 18.02k | 0.00 | Derivative Exercise and Retained Stock | - | 2.48M | 0.73% |
| 2026-03-31 | Dr. AmirAli TalasazCo-CEO & Director | -18.52k | 1.69M | Derivative Exercise and Sale | 91.15 - 92.37 | 2.48M | - |
| 2026-03-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 18.02k | 0.00 | Derivative Exercise and Retained Stock | - | 2.44M | 0.74% |
| 2026-03-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -18.52k | 1.69M | Derivative Exercise and Sale | 91.15 - 92.37 | 2.44M | - |
| 2026-03-31 | Mr. Steve Edward KrognesIndependent Director | 155.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.21k | 0.81% |
| 2026-03-21 | Mr. Roberto Agostino MignoneIndependent Director | 264.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.49k | 6.25% |
| 2026-03-18 | Mr. Musa TariqIndependent Director | -348.00 | 30.66k | 売り | 88.09 | 8.39k | -3.98% |
| 2026-03-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.43k | 19.45% |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 32.18k | 0.00 | Derivative Exercise and Retained Stock | - | 2.42M | 1.35% |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -33.07k | 3.15M | Derivative Exercise and Sale | 85.49 - 102.14 | 2.42M | - |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -13.21k | 0.00 | Other Disposition | - | 2.42M | -0.54% |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | 32.18k | 0.00 | Derivative Exercise and Retained Stock | - | 2.46M | 1.32% |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | -33.07k | 3.15M | Derivative Exercise and Sale | 85.49 - 102.14 | 2.46M | - |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | -13.21k | 0.00 | Other Disposition | - | 2.46M | -0.53% |
| 2026-03-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 4.19k | 0.00 | Derivative Exercise and Retained Stock | - | 56.90k | 7.95% |
| 2026-03-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -4.62k | 395.13k | Derivative Exercise and Sale | 85.49 | 56.90k | - |
| 2026-03-15 | Mr. Kumud KaliaChief Information Officer | 6.65k | 0.00 | Derivative Exercise and Retained Stock | - | 44.30k | 17.68% |
| 2026-03-15 | Mr. Kumud KaliaChief Information Officer | -6.84k | 584.67k | Derivative Exercise and Sale | 85.49 | 44.30k | - |
| 2026-03-15 | Mr. Musa TariqIndependent Director | 249.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.74k | 2.93% |
| 2026-03-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 9.70k | 0.00 | Derivative Exercise and Retained Stock | - | 53.57k | 22.11% |
| 2026-03-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -7.13k | 609.29k | Derivative Exercise and Sale | 85.49 | 53.57k | - |
| 2026-03-15 | Dr. Craig Eagleインサイダー | 7.45k | 0.00 | Derivative Exercise and Retained Stock | - | 66.38k | 12.65% |
| 2026-03-15 | Dr. Craig Eagleインサイダー | -7.66k | 654.94k | Derivative Exercise and Sale | 85.49 | 66.38k | - |
| 2026-03-15 | Dr. Darya ChudovaCTO | 4.96k | 0.00 | Derivative Exercise and Retained Stock | - | 73.89k | 7.19% |
| 2026-03-15 | Dr. Darya ChudovaCTO | -5.76k | 492.34k | Derivative Exercise and Sale | 85.49 | 73.89k | - |
| 2026-03-15 | Mr. Michael BellCFO | 3.38k | 0.00 | Derivative Exercise and Retained Stock | - | 43.60k | 8.40% |
| 2026-03-15 | Mr. Michael BellCFO | -10.41k | 894.85k | Derivative Exercise and Sale | 85.49 - 87.04 | 43.60k | - |
| 2026-03-06 | Dr. Manuel Hidalgo MedinaIndependent Director | -1,000.00 | 59.06k | Derivative Exercise and Sale | 32.55 - 91.61 | 1.19k | - |
| 2026-03-06 | Dr. Manuel Hidalgo MedinaIndependent Director | -300.00 | 27.39k | 売り | 91.30 | 1.19k | -20.09% |
| 2026-03-04 | Mr. Kumud KaliaChief Information Officer | 3.12k | 147.22k | Derivative Exercise and Retained Stock | 47.20 | 37.64k | 9.03% |
| 2026-03-04 | Mr. Kumud KaliaChief Information Officer | -40.00k | 2.34M | Derivative Exercise and Sale | 28.37 - 95.73 | 37.64k | - |
| 2026-02-28 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.05k | 0.81% |
| 2026-02-21 | Mr. Roberto Agostino MignoneIndependent Director | 264.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.22k | 6.67% |
| 2026-02-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.49k | 18.40% |
| 2026-02-15 | Mr. Musa TariqIndependent Director | 250.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.49k | 3.03% |
| 2026-01-31 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.90k | 0.82% |
| 2026-01-21 | Mr. Roberto Agostino MignoneIndependent Director | 264.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.96k | 7.14% |
| 2026-01-21 | Ms. Terilyn Juarez MonroeCPO | -8.57k | 977.90k | 売り | 112.34 - 115.70 | 20.99k | -28.99% |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | -2.08M | 0.00 | Other Disposition | - | 2.43M | -46.13% |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -2.05M | 0.00 | Other Disposition | - | 2.39M | -46.15% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -47.92k | 0.00 | Other Disposition | - | 68.94k | -41.01% |
| 2026-01-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.26k | 22.55% |
| 2026-01-15 | Mr. Musa TariqIndependent Director | 250.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.24k | 3.13% |
| 2026-01-15 | Ms. Terilyn Juarez MonroeCPO | 8.57k | 0.00 | Derivative Exercise and Retained Stock | - | 29.56k | 40.83% |
| 2026-01-15 | Ms. Terilyn Juarez MonroeCPO | -8.81k | 986.32k | Derivative Exercise and Sale | 111.98 | 29.56k | - |
| 2026-01-07 | Ms. Terilyn Juarez MonroeCPO | -10.03k | 1.12M | 売り | 111.75 - 113.44 | 20.99k | -32.34% |
| 2026-01-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 9.06k | 0.00 | Derivative Exercise and Retained Stock | - | 52.71k | 20.75% |
| 2026-01-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -9.99k | 1.02M | Derivative Exercise and Sale | 102.14 | 52.71k | - |
| 2026-01-01 | Ms. Terilyn Juarez MonroeCPO | 10.03k | 0.00 | Derivative Exercise and Retained Stock | - | 31.02k | 47.79% |
| 2026-01-01 | Ms. Terilyn Juarez MonroeCPO | -7.52k | 768.50k | Derivative Exercise and Sale | 102.14 | 31.02k | - |
| 2026-01-01 | Mr. Kumud KaliaChief Information Officer | 11.85k | 0.00 | Derivative Exercise and Retained Stock | - | 34.52k | 52.23% |
| 2026-01-01 | Mr. Kumud KaliaChief Information Officer | -9.39k | 959.30k | Derivative Exercise and Sale | 102.14 | 34.52k | - |
| 2026-01-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 17.08k | 0.00 | Derivative Exercise and Retained Stock | - | 43.87k | 63.72% |
| 2026-01-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -10.16k | 1.04M | Derivative Exercise and Sale | 102.14 | 43.87k | - |
| 2026-01-01 | Dr. Craig Eagleインサイダー | 13.92k | 0.00 | Derivative Exercise and Retained Stock | - | 58.93k | 30.93% |
| 2026-01-01 | Dr. Craig Eagleインサイダー | -11.52k | 1.18M | Derivative Exercise and Sale | 102.14 | 58.93k | - |
| 2026-01-01 | Dr. Darya ChudovaCTO | 10.42k | 0.00 | Derivative Exercise and Retained Stock | - | 71.91k | 16.94% |
| 2026-01-01 | Dr. Darya ChudovaCTO | -12.32k | 1.26M | Derivative Exercise and Sale | 102.14 | 71.91k | - |
| 2026-01-01 | Mr. Michael BellCFO | 10.56k | 0.00 | Derivative Exercise and Retained Stock | - | 40.22k | 35.59% |
| 2026-01-01 | Mr. Michael BellCFO | -12.48k | 1.27M | Derivative Exercise and Sale | 102.14 | 40.22k | - |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | 15.58k | 0.00 | Derivative Exercise and Retained Stock | - | 2.01M | 0.78% |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | -13.23k | 1.35M | Derivative Exercise and Sale | 102.14 | 2.01M | - |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 15.58k | 0.00 | Derivative Exercise and Retained Stock | - | 2.39M | 0.66% |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -13.23k | 1.35M | Derivative Exercise and Sale | 102.14 | 2.39M | - |
| 2025-12-31 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.75k | 0.83% |
| 2025-12-21 | Mr. Roberto Agostino MignoneIndependent Director | 264.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.70k | 7.69% |
| 2025-12-17 | Mr. Musa TariqIndependent Director | -116.00 | 11.77k | 売り | 101.46 | 7.99k | -1.43% |
| 2025-12-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.03k | 29.11% |
| 2025-12-15 | Mr. Musa TariqIndependent Director | 250.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.11k | 3.18% |
| 2025-12-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 485.00 | 0.00 | Derivative Exercise and Retained Stock | - | 43.66k | 1.12% |
| 2025-12-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535.00 | 54.93k | Derivative Exercise and Sale | 102.67 | 43.66k | - |
| 2025-12-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808.00 | 0.00 | Derivative Exercise and Retained Stock | - | 26.80k | 3.11% |
| 2025-12-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594.00 | 60.99k | Derivative Exercise and Sale | 102.67 | 26.80k | - |
| 2025-12-15 | Mr. Kumud KaliaChief Information Officer | 314.00 | 0.00 | Derivative Exercise and Retained Stock | - | 22.68k | 1.40% |
| 2025-12-15 | Mr. Kumud KaliaChief Information Officer | -323.00 | 33.16k | Derivative Exercise and Sale | 102.67 | 22.68k | - |
| 2025-12-15 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -90.57k | 9.40M | 売り | 103.80 - 104.02 | 2.38M | -3.67% |
| 2025-12-15 | Dr. Craig Eagleインサイダー | 691.00 | 0.00 | Derivative Exercise and Retained Stock | - | 45.01k | 1.56% |
| 2025-12-15 | Dr. Craig Eagleインサイダー | -711.00 | 73.00k | Derivative Exercise and Sale | 102.67 | 45.01k | - |
| 2025-12-15 | Dr. Darya ChudovaCTO | -5.45k | 567.13k | 売り | 104.04 | 61.49k | -8.14% |
| 2025-12-15 | Mr. Michael BellCFO | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 29.67k | 5.75% |
| 2025-12-15 | Mr. Michael BellCFO | -1.66k | 170.33k | Derivative Exercise and Sale | 102.67 | 29.67k | - |
| 2025-12-08 | Dr. AmirAli TalasazCo-CEO & Director | -387.95k | 0.00 | Other Disposition | - | 2.42M | -13.83% |
| 2025-12-08 | Dr. AmirAli TalasazCo-CEO & Director | -100.00k | 10.51M | 売り | 104.21 - 106.00 | 2.42M | -3.97% |
| 2025-12-08 | Mr. Kumud KaliaChief Information Officer | -2.00k | 209.20k | 売り | 104.60 | 22.37k | -8.21% |
| 2025-12-08 | Dr. Manuel Hidalgo MedinaIndependent Director | -1,000.00 | 72.45k | Derivative Exercise and Sale | 32.55 - 105.00 | 797.00 | - |
| 2025-12-08 | Dr. Manuel Hidalgo MedinaIndependent Director | -250.00 | 26.25k | 売り | 105.00 | 797.00 | -23.88% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -22.94k | 2.42M | 売り | 105.04 - 106.00 | 66.94k | -25.52% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -68.14k | 0.00 | Other Disposition | - | 66.94k | -50.44% |
| 2025-12-05 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -31.45k | 3.24M | 売り | 101.40 - 106.71 | 25.99k | -54.76% |
| 2025-12-05 | Mr. Michael BellCFO | -56.29k | 4.07M | Derivative Exercise and Sale | 28.37 - 106.68 | 28.05k | - |
| 2025-12-05 | Mr. Michael BellCFO | -24.08k | 2.49M | 売り | 101.46 - 107.26 | 28.05k | -46.19% |
| 2025-12-05 | Mr. Ian T. ClarkLead Independent Director | -28.61k | 2.04M | Derivative Exercise and Sale | 31.84 - 108.05 | 9.85k | - |
| 2025-12-01 | Ms. Terilyn Juarez MonroeCPO | -50.00k | 4.16M | Derivative Exercise and Sale | 20.14 - 107.85 | 20.92k | - |
| 2025-12-01 | Ms. Terilyn Juarez MonroeCPO | -5.17k | 547.68k | 売り | 105.33 - 107.03 | 20.92k | -19.81% |
| 2025-11-30 | Mr. Steve Edward KrognesIndependent Director | 155.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.59k | 0.84% |
| 2025-11-21 | Mr. Roberto Agostino MignoneIndependent Director | 264.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.43k | 8.34% |
| 2025-11-19 | Mr. Musa TariqIndependent Director | -116.00 | 11.17k | 売り | 96.25 | 7.86k | -1.45% |
| 2025-11-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.05k | 28.47% |
| 2025-11-15 | Mr. Musa TariqIndependent Director | 250.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.98k | 3.24% |
| 2025-11-07 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -9.00k | 865.87k | 売り | 96.25 | 43.17k | -17.24% |
| 2025-11-07 | Dr. Manuel Hidalgo MedinaIndependent Director | -1,000.00 | 62.62k | Derivative Exercise and Sale | 32.55 - 95.17 | 815.00 | - |
| 2025-11-07 | Dr. Manuel Hidalgo MedinaIndependent Director | -500.00 | 47.62k | 売り | 95.23 | 815.00 | -38.02% |
| 2025-10-31 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.44k | 0.84% |
| 2025-10-21 | Mr. Roberto Agostino MignoneIndependent Director | 3.17k | 0.00 | Derivative Exercise and Retained Stock | - | 3.17k | - |
| 2025-10-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.32k | 21.42% |
| 2025-10-17 | Mr. Musa TariqIndependent Director | -116.00 | 7.77k | 売り | 66.95 | 7.73k | -1.48% |
| 2025-10-17 | Ms. Myrtle S. PotterIndependent Director | -26.00 | 1.74k | 売り | 66.95 | 18.32k | -0.14% |
| 2025-10-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 6.74k | 0.00 | Derivative Exercise and Retained Stock | - | 52.17k | 14.83% |
| 2025-10-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -7.43k | 465.55k | Derivative Exercise and Sale | 62.65 | 52.17k | - |
| 2025-10-01 | Mr. Kumud KaliaChief Information Officer | 5.20k | 0.00 | Derivative Exercise and Retained Stock | - | 24.37k | 27.14% |
| 2025-10-01 | Mr. Kumud KaliaChief Information Officer | -5.35k | 335.05k | Derivative Exercise and Sale | 62.65 | 24.37k | - |
| 2025-10-01 | Ms. Terilyn Juarez MonroeCPO | 5.17k | 0.00 | Derivative Exercise and Retained Stock | - | 26.09k | 24.70% |
| 2025-10-01 | Ms. Terilyn Juarez MonroeCPO | -5.31k | 332.67k | Derivative Exercise and Sale | 62.65 | 26.09k | - |
| 2025-10-01 | Dr. Craig Eagleインサイダー | 6.83k | 0.00 | Derivative Exercise and Retained Stock | - | 44.32k | 18.23% |
| 2025-10-01 | Dr. Craig Eagleインサイダー | -7.03k | 440.12k | Derivative Exercise and Sale | 62.65 | 44.32k | - |
| 2025-10-01 | Dr. Darya ChudovaCTO | 7.94k | 0.00 | Derivative Exercise and Retained Stock | - | 89.39k | 9.75% |
| 2025-10-01 | Dr. Darya ChudovaCTO | -8.16k | 511.41k | Derivative Exercise and Sale | 62.65 | 89.39k | - |
| 2025-10-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 7.81k | 0.00 | Derivative Exercise and Retained Stock | - | 57.44k | 15.74% |
| 2025-10-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -5.74k | 359.61k | Derivative Exercise and Sale | 62.65 | 57.44k | - |
| 2025-09-30 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.28k | 0.85% |
| 2025-10-01 | Mr. Michael BellCFO | 7.49k | 0.00 | Derivative Exercise and Retained Stock | - | 52.13k | 16.77% |
| 2025-10-01 | Mr. Michael BellCFO | -7.70k | 482.09k | Derivative Exercise and Sale | 62.65 | 52.13k | - |
| 2025-09-30 | Dr. AmirAli TalasazCo-CEO & Director | 14.21k | 0.00 | Derivative Exercise and Retained Stock | - | 2.52M | 0.57% |
| 2025-09-30 | Dr. AmirAli TalasazCo-CEO & Director | -14.60k | 914.40k | Derivative Exercise and Sale | 62.48 - 62.65 | 2.52M | - |
| 2025-09-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 14.21k | 0.00 | Derivative Exercise and Retained Stock | - | 2.47M | 0.58% |
| 2025-09-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -14.60k | 914.40k | Derivative Exercise and Sale | 62.48 - 62.65 | 2.47M | - |
| 2025-09-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.08k | 27.26% |
| 2025-09-15 | Mr. Musa TariqIndependent Director | 133.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.59k | 1.78% |
| 2025-09-15 | Mr. Musa TariqIndependent Director | -116.00 | 6.45k | Derivative Exercise and Sale | 55.63 | 7.59k | - |
| 2025-09-15 | Ms. Myrtle S. PotterIndependent Director | 42.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.28k | 0.23% |
| 2025-09-15 | Ms. Myrtle S. PotterIndependent Director | -26.00 | 1.45k | Derivative Exercise and Sale | 55.63 | 18.28k | - |
| 2025-09-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 484.00 | 0.00 | Derivative Exercise and Retained Stock | - | 45.43k | 1.08% |
| 2025-09-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535.00 | 29.31k | Derivative Exercise and Sale | 54.79 | 45.43k | - |
| 2025-09-15 | Mr. Kumud KaliaChief Information Officer | 314.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.16k | 1.67% |
| 2025-09-15 | Mr. Kumud KaliaChief Information Officer | -324.00 | 17.75k | Derivative Exercise and Sale | 54.79 | 19.16k | - |
| 2025-09-15 | Dr. Craig Eagleインサイダー | 691.00 | 0.00 | Derivative Exercise and Retained Stock | - | 37.48k | 1.88% |
| 2025-09-15 | Dr. Craig Eagleインサイダー | -711.00 | 38.96k | Derivative Exercise and Sale | 54.79 | 37.48k | - |
| 2025-09-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808.00 | 0.00 | Derivative Exercise and Retained Stock | - | 49.63k | 1.66% |
| 2025-09-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594.00 | 32.55k | Derivative Exercise and Sale | 54.79 | 49.63k | - |
| 2025-09-15 | Mr. Michael BellCFO | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 44.64k | 3.75% |
| 2025-09-15 | Mr. Michael BellCFO | -1.66k | 90.90k | Derivative Exercise and Sale | 54.79 | 44.64k | - |
| 2025-09-12 | Dr. Manuel Hidalgo MedinaIndependent Director | -2.17k | 117.25k | 売り | 54.16 | 851.00 | -71.78% |
| 2025-09-09 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -300.00k | 17.84M | 売り | 59.44 - 59.93 | 2.45M | -10.90% |
| 2025-09-02 | Ms. Meghan V. JoyceIndependent Director | -100.00 | 6.58k | 売り | 65.84 | 11.18k | -0.89% |
| 2025-09-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 125.00 | 0.00 | Derivative Exercise and Retained Stock | - | 44.95k | 0.28% |
| 2025-09-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -139.00 | 9.37k | Derivative Exercise and Sale | 67.42 | 44.95k | - |
| 2025-09-01 | Mr. Kumud KaliaChief Information Officer | 350.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.85k | 1.89% |
| 2025-09-01 | Mr. Kumud KaliaChief Information Officer | -361.00 | 24.34k | Derivative Exercise and Sale | 67.42 | 18.85k | - |
| 2025-09-01 | Dr. Darya ChudovaCTO | 155.00 | 0.00 | Derivative Exercise and Retained Stock | - | 81.45k | 0.19% |
| 2025-09-01 | Dr. Darya ChudovaCTO | -161.00 | 10.85k | Derivative Exercise and Sale | 67.42 | 81.45k | - |
| 2025-08-31 | Mr. Steve Edward KrognesIndependent Director | 155.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.13k | 0.86% |
| 2025-08-21 | Mr. Kumud KaliaChief Information Officer | -2.00k | 123.51k | 売り | 61.76 | 18.50k | -9.76% |
| 2025-08-19 | Mr. Musa TariqIndependent Director | -116.00 | 6.85k | 売り | 59.02 | 7.46k | -1.53% |
| 2025-08-19 | Ms. Myrtle S. PotterIndependent Director | -26.00 | 1.53k | 売り | 59.02 | 18.24k | -0.14% |
| 2025-08-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.02k | 8.33% |
| 2025-08-15 | Mr. Musa TariqIndependent Director | 250.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.57k | 3.41% |
| 2025-08-15 | Ms. Myrtle S. PotterIndependent Director | 69.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.27k | 0.38% |
| 2025-08-04 | Ms. Meghan V. JoyceIndependent Director | 67.00 | 0.00 | Derivative Exercise and Retained Stock | - | 11.28k | 0.60% |
| 2025-07-31 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 17.97k | 0.86% |
| 2025-07-17 | Mr. Musa TariqIndependent Director | -116.00 | 5.59k | 売り | 48.20 | 7.32k | -1.56% |
| 2025-07-17 | Ms. Myrtle S. PotterIndependent Director | -26.00 | 1.25k | 売り | 48.20 | 18.20k | -0.14% |
| 2025-07-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 2.78k | 0.00 | Derivative Exercise and Retained Stock | - | 2.78k | - |
| 2025-07-15 | Mr. Musa TariqIndependent Director | 250.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.44k | 3.48% |
| 2025-07-15 | Ms. Myrtle S. PotterIndependent Director | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 18.22k | 0.37% |
| 2025-07-04 | Ms. Meghan V. JoyceIndependent Director | 66.00 | 0.00 | Derivative Exercise and Retained Stock | - | 11.22k | 0.59% |
| 2025-07-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 1.26k | 0.00 | Derivative Exercise and Retained Stock | - | 44.82k | 2.88% |
| 2025-07-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -1.39k | 70.28k | Derivative Exercise and Sale | 50.71 | 44.82k | - |
| 2025-07-01 | Mr. Kumud KaliaChief Information Officer | 1.33k | 0.00 | Derivative Exercise and Retained Stock | - | 20.50k | 6.92% |
| 2025-07-01 | Mr. Kumud KaliaChief Information Officer | -1.37k | 69.22k | Derivative Exercise and Sale | 50.71 | 20.50k | - |
| 2025-07-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 2.06k | 0.00 | Derivative Exercise and Retained Stock | - | 48.82k | 4.41% |
| 2025-07-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -1.53k | 77.69k | Derivative Exercise and Sale | 50.71 | 48.82k | - |
| 2025-07-01 | Dr. Craig Eagleインサイダー | 1.67k | 0.00 | Derivative Exercise and Retained Stock | - | 36.79k | 4.75% |
| 2025-07-01 | Dr. Craig Eagleインサイダー | -1.71k | 86.92k | Derivative Exercise and Sale | 50.71 | 36.79k | - |
| 2025-07-01 | Dr. Darya ChudovaCTO | 1.48k | 0.00 | Derivative Exercise and Retained Stock | - | 81.29k | 1.86% |
| 2025-07-01 | Dr. Darya ChudovaCTO | -1.53k | 77.33k | Derivative Exercise and Sale | 50.71 | 81.29k | - |
| 2025-07-01 | Mr. Michael BellCFO | 1.03k | 0.00 | Derivative Exercise and Retained Stock | - | 43.03k | 2.45% |
| 2025-07-01 | Mr. Michael BellCFO | -1.06k | 53.60k | Derivative Exercise and Sale | 50.71 | 43.03k | - |
| 2025-07-01 | Dr. AmirAli TalasazCo-CEO & Director | 24.00k | 0.00 | Derivative Exercise and Retained Stock | - | 2.50M | 0.97% |
| 2025-06-30 | Dr. AmirAli TalasazCo-CEO & Director | -4.82k | 247.32k | Derivative Exercise and Sale | 50.67 - 52.04 | 2.50M | - |
| 2025-07-01 | Dr. AmirAli TalasazCo-CEO & Director | -97.63k | 4.97M | Automatic Disposition | 50.67 - 51.40 | 2.50M | -3.75% |
| 2025-07-01 | Dr. AmirAli TalasazCo-CEO & Director | -12.16k | 616.74k | Sale to Issuer | 50.71 | 2.50M | -0.48% |
| 2025-06-30 | Mr. Steve Edward KrognesIndependent Director | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 17.82k | 0.87% |
| 2025-06-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 14.21k | 0.00 | Derivative Exercise and Retained Stock | - | 2.75M | 0.52% |
| 2025-06-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -14.60k | 743.76k | Derivative Exercise and Sale | 50.71 - 52.04 | 2.75M | - |
| 2025-06-18 | Mr. Musa TariqIndependent Director | -3.21k | 158.95k | 売り | 49.47 | 7.19k | -30.89% |
| 2025-06-18 | Ms. Myrtle S. PotterIndependent Director | -26.00 | 1.29k | 売り | 49.47 | 18.15k | -0.14% |
| 2025-06-17 | Mr. Ian T. ClarkLead Independent Director | -6.67k | 322.82k | 売り | 48.38 | 9.85k | -40.38% |
| 2025-06-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 485.00 | 0.00 | Derivative Exercise and Retained Stock | - | 43.57k | 1.13% |
| 2025-06-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535.00 | 26.37k | Derivative Exercise and Sale | 49.29 | 43.57k | - |
| 2025-06-15 | Mr. Kumud KaliaChief Information Officer | 409.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.17k | 2.18% |
| 2025-06-15 | Mr. Kumud KaliaChief Information Officer | -228.00 | 11.24k | Derivative Exercise and Sale | 49.29 | 19.17k | - |
| 2025-06-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 3.61k | 0.00 | Derivative Exercise and Retained Stock | - | 46.76k | 8.36% |
| 2025-06-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -2.68k | 131.85k | Derivative Exercise and Sale | 49.29 | 46.76k | - |
| 2025-06-15 | Dr. Craig Eagleインサイダー | 691.00 | 0.00 | Derivative Exercise and Retained Stock | - | 35.12k | 2.01% |
| 2025-06-15 | Dr. Craig Eagleインサイダー | -711.00 | 35.05k | Derivative Exercise and Sale | 49.29 | 35.12k | - |
| 2025-06-15 | Mr. Michael BellCFO | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 42.00k | 3.99% |
| 2025-06-15 | Mr. Michael BellCFO | -1.66k | 81.77k | Derivative Exercise and Sale | 49.29 | 42.00k | - |
| 2025-06-12 | Ms. Myrtle S. PotterIndependent Director | 4.12k | 0.00 | Derivative Exercise and Retained Stock | - | 18.18k | 29.28% |
| 2025-06-12 | Ms. Myrtle S. PotterIndependent Director | -2.63k | 130.51k | Derivative Exercise and Sale | 49.70 | 18.18k | - |
| 2025-06-12 | Ms. Meghan V. JoyceIndependent Director | 3.34k | 0.00 | Derivative Exercise and Retained Stock | - | 11.15k | 42.71% |
| 2025-06-12 | Ms. Meghan V. JoyceIndependent Director | -3.34k | 157.57k | Derivative Exercise and Sale | 47.22 | 11.15k | - |
| 2025-06-12 | Mr. Musa TariqIndependent Director | 6.92k | 0.00 | Derivative Exercise and Retained Stock | - | 10.40k | 199.02% |
| 2025-06-12 | Mr. Steve Edward KrognesIndependent Director | 6.67k | 0.00 | Derivative Exercise and Retained Stock | - | 17.67k | 60.72% |
| 2025-06-12 | Ms. Vijaya GaddeIndependent Director | 6.67k | 0.00 | Derivative Exercise and Retained Stock | - | 24.31k | 37.83% |
| 2025-06-12 | Mr. Ian T. ClarkLead Independent Director | 8.09k | 0.00 | Derivative Exercise and Retained Stock | - | 16.52k | 95.89% |
| 2025-06-05 | Dr. AmirAli TalasazCo-CEO & Director | -119.28k | 5.97M | Automatic Disposition | 50.00 - 50.09 | 2.59M | -4.40% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
